National Cancer Institute; Amended Notice of Meeting
---
identifier: "/us/fr/2021-11106"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2021-11106"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2021-05-26"
last_updated: "2021-05-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2021-11106"
document_type: "notice"
publication_date: "2021-05-26"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "86 FR 28371"
fr_volume: 86
---
# National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee, July 14, 2021, 11:00 a.m. to July 14, 2021, 2:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850, which was published in the *Federal Register* on May 20, 2021, 86 FR 27458.
This meeting notice is amended to change the meeting end time. The meeting will now be held from 11:00 a.m. to 3:00 p.m. on July 14, 2021. The meeting will be held as a virtual meeting and is open to the public.
Dated: May 20, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.